Associated Papers
Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrum.
Breen KE et al.
Npj Precision Oncology, 2025
CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas.
Hickman RA et al.
Acta Neuropathologica, 2023
37831210 (PubMed )
Supplement: 401_2023_2639_MOESM2_ESM.docx
Clinical benefit for clinical sequencing using cancer panel testing.
Nishimura S et al.
Plos One, 2021
33635883 (PubMed )
Supplement: pone.0247090.s006.xlsx › Supplemental_table_S5
Select a paper to view details